早期宫颈癌根治性子宫切除术:微创手术与开腹手术的生存结局比较
本研究回顾性纳入2007至2017年单中心196例早期宫颈癌(IA1伴LVSI、IA2或IB1)根治性子宫切除术患者,比较微创手术(MIS,117例,其中机器人106例)与开腹手术(79例)的肿瘤学及围手术期结局。中位随访约4年,两组5年无病生存率、疾病特异性生存率和总生存率均无显著差异,MIS组术后并发症率显著更低。多因素回归分析显示MIS与DFS、DSS或OS无关。
要点
- MIS组与开腹组5年DFS、DSS、OS均无显著差异。
- MIS组术后并发症率显著低于开腹组(11.1% vs 20.3%,P=0.04)。
- 开腹组阳性淋巴结比例和辅助治疗比例更高(P=0.046和P=0.006)。
核心结论
- 在单中心同期系列早期宫颈癌患者中,微创根治性子宫切除术未导致更差的肿瘤学结局。
研究设计与样本
- 回顾性队列研究,纳入2007年1月至2017年12月单中心196例早期宫颈癌(IA1伴LVSI、IA2或IB1)根治性子宫切除术患者,其中MIS组117例(机器人106例,90.6%),开腹组79例。
主要发现
- MIS组子宫切除标本无残留肿瘤者更多(24.8% vs 10.1%,P=0.01)。
- 开腹组阳性淋巴结更多(29.1% vs 17.1%,P=0.046),接受辅助治疗者更多(53.2% vs 33.3%,P=0.006)。
- 中位随访约4年,5年DFS率MIS组87.0% vs 开腹组86.6%(P=0.92)。
- 5年DSS率MIS组96.5% vs 开腹组93.9%(P=0.93),5年OS率96.5% vs 87.4%(P=0.15)。
- 多因素回归分析显示MIS与DFS、DSS或OS无关。
临床怎么用
- 对于早期宫颈癌,微创根治性子宫切除术在本单中心研究中未显示更差生存,且并发症更少,可作为可选术式之一。
局限性
- 本研究为单中心回顾性研究,样本量有限,可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare oncologic and perioperative outcomes in patients who underwent minimally invasive surgery (MIS) compared to laparotomy for newly diagnosed early-stage cervical carcinoma. METHODS: We retrospectively identified patients who underwent radical hysterectomy for stage IA1 with lymphovascular invasion (LVI), IA2, or IB1 cervical carcinoma at our institution from 1/2007-12/2017. Clinicopathologic characteristics and surgical and oncologic survival outcomes were compared using appropriate statistical testing. Multivariable Cox regression analysis was used to control for potential confounders. RESULTS: We identified 196 evaluable cases-117 MIS (106 robotic [90.6%]) and 79 laparotomy cases. Cohorts had similar age, BMI, substage, histologic subtype, clinical and pathologic tumor size, positive margins, and presence of LVI. The MIS group had more cases with no residual tumor in the hysterectomy (24.8% vs. 10.1%, P = 0.01). The laparotomy group had more cases with positive nodes (29.1% vs. 17.1%, P = 0.046) and more patients who received adjuvant therapy (53.2% vs. 33.3%, P = 0.006). Median follow-up was ~4 years. Five-year disease-free survival (DFS) rates were 87.0% in the MIS group and 86.6% in the laparotomy group (P = 0.92); 5-year disease-specific survival (DSS) rates were 96.5% and 93.9%, respectively (P = 0.93); and 5-year overall survival (OS) rates were 96.5% and 87.4%, respectively (P = 0.15). MIS was not associated with DFS, DSS, or OS on multivariable regression analysis. The rate of postoperative complications was significantly lower in the MIS cohort (11.1% vs. 20.3%; P = 0.04). CONCLUSIONS: MIS radical hysterectomy for cervical carcinoma did not confer worse oncologic outcomes in our single-center and concurrent series of patients with early-stage cervical carcinoma.
引用
- Brandt B, Sioulas V, Basaran D, et al. Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes. Gynecol Oncol. 2020. PMID: 31918996. doi:10.1016/j.ygyno.2019.12.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。